| Sleep apnea and the heart: diagnosis and treatment. | |
| | |
MedLine Citation:
|
PMID: 18953275 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although sleep apnea is closely associated with cardiovascular disease, it remains underdiagnosed and undertreated. Obstructive sleep apnea elicits a cascade of harmful cardiovascular stimuli, and central sleep apnea is a prognostic factor for heart failure and may exert adverse effects on outcomes. The adverse effects of obstructive sleep apnea can promote the development of atherosclerosis and have also been implicated in the pathogenesis of cardiovascular disease. Sleep apnea characterized by variables of the autonomic nervous system may have a direct association with arrhythmia. Polysomnography with electroencephalography is the gold standard for assessing sleep apnea. Alternative methods of screening for OSA have recently become available. Continuous positive airway pressure for obstructive sleep apnea reduces cardiac risk and cardiovascular disease mortality. Targeting sleep apnea in the primary and/or secondary prevention of cardiovascular disease may lead to better outcomes. |
| | |
Authors:
|
Dai Yumino; Hiroshi Kasanuki |
Related Documents
:
|
14592255 - Marital satisfaction of wives of untreated sleep apneic men. 17249525 - A new technique for detecting sleep apnea-related "midnight" surge of blood pressure. 2371595 - Verification of sleep apnea using a portable sleep apnea screening device. 8049835 - Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central s... 9771165 - Exploitation of elasticity in copying geometrical patterns: the role of age, movement a... 11381065 - Soluble tnf receptors in vitreoretinal proliferative disease. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Reviews in cardiovascular medicine Volume: 9 ISSN: 1530-6550 ISO Abbreviation: Rev Cardiovasc Med Publication Date: 2008 |
Date Detail:
|
Created Date: 2008-10-27 Completed Date: 2008-11-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100960007 Medline TA: Rev Cardiovasc Med Country: United States |
Other Details:
|
Languages: eng Pagination: 159-67 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiovascular Agents
/
therapeutic use Cardiovascular Diseases / etiology, therapy* Continuous Positive Airway Pressure Electroencephalography Heart Failure / etiology, prevention & control Humans Polysomnography Sleep Apnea Syndromes / complications, diagnosis*, therapy* Sleep Apnea, Central / complications, diagnosis*, therapy* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nesiritide in acute decompensated heart failure: current status and future perspectives.
Next Document: Patent foramen ovale: clinical manifestations and treatment.